Mechanism of action and value of N-Acetylcysteine in the treatment of early and late acetaminophen poisoning: A critical review

Journal of Toxicology - Clinical Toxicology

Volumn 36, Issue 4, 1998, Pages 277-285

  Jones, Alison L ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; ENZYME INDUCTION; HUMAN; LIVER BLOOD FLOW; LIVER FAILURE; MEAN ARTERIAL PRESSURE; REVIEW; SURVIVAL RATE;

EID: 0031902252     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659809028022     Document Type: Review

References (75)

1. Gunnell D, Hawton K, Murray V, et al. Use of para-cetamol for suicide and non-fatal poisoning in the UK and France: Are restrictions on availability justified? J Epidemiol Community Health 1997;51:175-179.
2. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. BMJ 1992;304: 1409-1411.
3. Annual Report of the Registrar General of Births, Deaths and Marriages for Scotland. HMSO, 1995.
4. Spooner JB, Harvey JG. Paracetamol overdosage-Facts, not misconceptions. Pharm J 1993;250:706-707.
5. Neeleman J, Wessely S. Drugs taken in fatal and non-fatal self-poisoning: A study in south London. Acta Psychiatr Scand 1997;95:283-287.
6. Litovitz TL, Smilkstein M, Felberg L, Klein-Schwartz W, Berlin R, Morgan JL. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1997;15:447-500.
7. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501-506.
8. Hultberg B, Andersson A, Masson P, Larson M, Tunek A. Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest 1994;54:417-422.
9. Borgstrom L, Kagedal B, Paulson O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 1986;31:217-222.
10. Sjodin K, Nilsson E, Hallberg A, Tunek A. Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochem Pharmacol 1989;38: 3981-3985.
11. Cotgreave IA, Berggren M, Jones TW, Dawson J, Moldeus P. Gastrointestinal metabolism of N-acetylcysteine in the rat, including an assay for sulfite in biological systems. Biopharm Drug Dispos 1987;8: 377-386.
12. Bonanomi L, Gazzaniga A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl 1980;111:45-51.
13. Sheffner AL, Medler EM, Bailey KR, Gallo DG, Mueller AJ, Sarett HP. Metabolic studies with acetylcysteine. Biochem Pharmacol 1966;15:1523-1535.
14. Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983;71:980-991.
15. Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF. Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 1997;11:787-791.
16. de Vries J. Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilate: Oxygenation or electron transfer? Biochem Pharmacol 1981;30:399-402.
17. Gemborys MW, Mudge GH, Gribble GW. Mechanism of decomposition of N-hydroxyacetaminophen, a postulated toxic metabolite of acetaminophen. J Med Chem 1980;23:304-308.
18. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gilette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vitro. J Pharmacol Exp Ther 1973;187:195-202.
19. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-194.
20. Potter WZ, Davis DC, Mitchell JR, Jollow DJ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther 1973;187:203-210.
21. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning. Br Med J 1979;2:1097-1100.
22. Mitchell JR, Jollow DJ, Gillette JR, Brodie BB. Drug metabolism as a cause of drug toxicity. Drug Metab Dispos 1973;1:418-423.
23. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen-induced hepatic injury: Protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther 1974;16:676-684.
24. Mitchell JR, Potter WZ. Drug metabolism in the production of liver injury. Med Clin North Am 1975; 59:877-885.
25. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211-217.
26. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976-1985). N Engl J Med 1988; 319:1557-1562.
27. Bizovi KE, Aks SE, Paloucek F, Gross R, Keys N, Rivas J. Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief. Ann Emerg Med 1996;28:549-551.
28. Minton NA, Henry JA, Frankel RJ. Fatal paracetamol poisoning in an epileptic. Hum Toxicol 1988;7:33-34.
29. Janes J, Routledge PA. Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Saf 1992;7:170-177.
30. Bray GP, Harrison PM, O'Grady JG, Tredger JM, Williams R. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol 1992;11:265-270.
31. Ferner R. Paracetamol poisoning - An update. Prescribers J 1993;33:45-50.
32. Johnston SC, Pelletier LL Jr. Enhancedhepatotoxicity of acetaminophen in the alcoholic patients. Two case reports and a review of the literature. Medicine (Baltimore) 1997:76:185-191.
33. Bray GP, Mowat C, Muir DF, Tredger JM, Williams R. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991;10:435-438.
34. McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980;244:251-253.
35. Girre C, Hispard E, Palombo S, N'Huyen C, Dally S. Increased metabolism of acetaminophen in chronically alcoholic patients. Alcohol Clin Exp Res 1993;17:170-173.
36. Prescott LF. Paracetamol (Acetaminophen). A Critical Bibliographic Review. London: Taylor & Francis, 1996.
37. Dhawan A, Sorrell MF. Acetaminophen overdose: Need to consider intravenous preparation of N-acetylcysteine in the United States. Am J Gastroenterol 1996;91:1476.
38. Ekins BR, Ford DC, Thompson MI, Bridges RR, Rollins DE, Jenkins RD. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med 1987;5:483-487.
39. Reed MD, Marx CM. Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother 1994;28:331-333.
40. Clark RF, Chen R, Wiliams SR, Johnson CL, Harchelroad F. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicol Clin Toxicol 1996;34:163-167.
41. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: A 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991;20:1058-1063.
42. Woo OF, Anderson IB, Kim SY, Mueller P, Keller K, Olson KR. Shorter duration of N-acetylcysteine (NAC) for acute acetaminophen poisoning. J Toxicol Clin Toxicol 1995;33:508.
43. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995;133:43-52.
44. de la Mata M, Meager A, Rolando N, et al. Tumor necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990;82:479-484.
45. Meredith TJ, Prescott LF, Vale JA. Why do patients still die from paracetamol poisoning? Br Med J (Clin Res Ed) 1986;293:345-346.
46. Tredger JM, O'Grady JG, Williams R. Why do patients still die after paracetamol poisoning. Br Med J (Clin Res Ed) 1986;293:756-757.
47. Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990;335:1572-1573.
48. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991;303:1026-1029.
49. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: Patho-physiology and management. Semin Liver Dis 1996; 16:379-388.
50. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995;109:1907-1916.
51. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852-1857.
52. Walsh TS, Hopton P, Lee A. Oxygen consumption is independent of oxygen delivery following N-acetylcysteine in fulminant hepatic failure. Intens Care Med 1996;22:S436.
53. Walsh TS, Hopton P, Lee A. The beneficial haemodynamic effects of N-acetylcysteine are shortlived in patients with fulminant hepatic failure. Intens Care Med 1996;22:S313.
54. Bartlett RH, Dechert RE. Oxygen kinetics: Pitfalls in clinical research. J Crit Care 1990;5:77-80.
55. Archie JP Jr. Mathematic coupling of data: A common source of error. Ann Surg 1981;193:296-303.
56. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997;25:236-242.
57. Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996;74:223-233.
58. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994;19:1407-1413.
59. Jaeschke H, Mitchell JR. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem Biophys Res Commun 1989;160:140-147.
60. Aruoma OI, Halliwell B, Hoey BM, Butler J. The anti-oxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6: 593-597.
61. Gressier B, Cabanis A, Lebegue S, et al. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production. Methods Find Exp Clin Pharmacol 1993;15:101-105.
62. Bruno MK, Cohen SD, Khairallah EA. Antidotal effectiveness of N-acetylcysteine in reversing acetaminophen-induced hepatotoxicity. Enhancement of the proteolysis of arylated proteins. Biochem Pharmacol 1988;37:4319-4325.
63. Hershkovitz E, Shorer Z, Levitas A, Tal A. Status epilepticus following intravenous N-acetylcysteine therapy. Isr J Med Sci 1996;32:1102-1104.
64. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989;150:329-331.
65. Death after N-acetylcysteine. Lancet 1984;1:1421.
66. Mroz LS, Benitez JG, Krenzelok EP. Angioedema with oral N-acetylcysteine. Ann Emerg Med 1997;30: 240-241.
67. Flanagan RJ, Meredith TJ. Use of N-acetylcysteine in clinical toxicology. Am J Med 1991;91:131S-139S.
68. Bonfiglio MF, Traeger SM, Hulisz DT, Martin BR. Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities. Ann Pharmacother 1992;26:22-25.
69. Bowden CA, Krenzelok EP. Clinical applications of commonly used contemporary antidotes. A US perspective. Drug Saf 1997;16:9-47.
70. Casey PB, Tracey JA. N-acetylcysteine (NAC) - A safe antidote in paracetamol poisoning? Ir Med J 1997;90:38.
71. Jones AL, Bangash IH, Bouchier IA, Hayes PC. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 1994;35:1290-1293.
72. Jones AL, Haynes W, MacGilchrist AJ, Webb DJ, Hayes PC. N-acetylcysteine acts as a potent peripheral vasodilator. Gut 1994;3S:S10;W40.
73. Overbeck HW, Grega GJ. Response of the limb vascular bed in man to intrabrachial arterial infusions of hypertonic dextrose or hypertonic sodium chloride solutions. Circ Res 1970;26:717-731.
74. Chong S, Fung HL. Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol 1991;42:1433-1439.
75. Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996;24:1302-1310.